AstraZeneca withdraws its marketing authorizations in Europe and withdraws its COVID-19vaccines worldwide due to low demand, after finding that the vaccines can very rarely lead to blood clots.
AstraZeneca withdraws its marketing authorizations in Europe and its COVID-19 vaccines worldwide due to low demand, after admitting its vaccines cause blood clots.
AstraZeneca withdraws its marketing authorizations in Europe and withdraws itsCOVID-19 vaccines worldwide due to low demand, after finding thatthevaccines canveryrarelyleadto blood clots.